首页    期刊浏览 2024年12月02日 星期一
登录注册

文章基本信息

  • 标题:Extensive neutralization against SARS-CoV-2 variants elicited by Omicron-specific subunit vaccine as a heterologous booster
  • 本地全文:下载
  • 作者:Pai Peng ; Chengqian Feng ; Jie Hu
  • 期刊名称:iScience
  • 印刷版ISSN:2589-0042
  • 出版年度:2022
  • 卷号:25
  • 期号:11
  • 页码:1-15
  • DOI:10.1016/j.isci.2022.105465
  • 语种:English
  • 出版社:Elsevier
  • 摘要:SummaryTo overcome the increased risk of SARS-CoV-2 reinfection or post-vaccination infection caused by the Omicron variant, Omicron-specific vaccines were considered a potential strategy. We reported the increased magnitude and breadth of antibody response against VOCs elicited by post-vaccination Delta and Omicron infection, compared to WT infection without vaccination. Then, in mouse models, three doses of Omicron-RBD immunization elicited comparable neutralizing antibody (NAb) titers with three doses of WT-RBD immunization, but the neutralizing activity was not cross-active. By contrast, a heterologous Omicron-RBD booster following two doses of WT-RBD immunization increased the NAb titers against Omicron by 9-folds than the homologous WT-RBD booster. Moreover, it retains neutralization against both WT and current VOCs. Results suggest that Omicron-specific subunit booster shows its advantages in the immune protection from both WT and current VOCs and that SARS-CoV-2 vaccines including two or more virus lineages might improve the NAb response.Graphical abstractDisplay OmittedHighlights•Post-vaccination SARS-CoV-2 infection can elicit higher and boarder immune response•A heterologous booster with the Omicron-RBD protein elicits a 9-fold increased NAb•Heterologous boosting with Omicron enhance the potency and breadth of immune responseVirology
国家哲学社会科学文献中心版权所有